Abbott Laboratories Stock Could Soar to 143, According to a Wall Street Analyst. Is It a Buy Around 108 - sharewise
| ABL Stock | EUR 109.76 0.24 0.22% |
Roughly 54% of Abbott Laboratories' investor base is interested to short. The analysis of current outlook of investing in Abbott Laboratories suggests that many traders are impartial regarding Abbott Laboratories' prospects. The current market sentiment, together with Abbott Laboratories' historical and current headlines, can help investors time the market. In addition, many technical investors use Abbott Laboratories stock news signals to limit their universe of possible portfolio assets.
Abbott Laboratories stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Abbott daily returns and investor perception about the current price of Abbott Laboratories as well as its diversification or hedging effects on your existing portfolios.
Abbott |
Abbott Laboratories Stock Could Soar to 143, According to a Wall Street Analyst. Is It a Buy Around 108 sharewise
Read at news.google.com
 |
Abbott Laboratories Fundamental Analysis
We analyze Abbott Laboratories' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Abbott Laboratories using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Abbott Laboratories based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
EBITDA
EBITDA Comparative Analysis
Abbott Laboratories is currently under evaluation in ebitda category among its peers. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Abbott Laboratories Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Abbott Laboratories stock to make a market-neutral strategy. Peer analysis of Abbott Laboratories could also be used in its relative valuation, which is a method of valuing Abbott Laboratories by comparing valuation metrics with similar companies.
Peers
Abbott Laboratories Related Equities
| UAO | Sterling Construction | 9.88 | ||||
| SGJH | Sinopec Shanghai | 7.14 | ||||
| TCW | Tokyu Construction | 0.00 | ||||
| V1M | CHEMICAL INDUSTRIES | 0.00 | ||||
| S9M | Silicon Motion | 0.94 | ||||
| NUF | Nufarm | 0.95 | ||||
| XFB | X-FAB Silicon | 4.03 |
Complementary Tools for Abbott Stock analysis
When running Abbott Laboratories' price analysis, check to measure Abbott Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abbott Laboratories is operating at the current time. Most of Abbott Laboratories' value examination focuses on studying past and present price action to predict the probability of Abbott Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abbott Laboratories' price. Additionally, you may evaluate how the addition of Abbott Laboratories to your portfolios can decrease your overall portfolio volatility.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |